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Abstract
Many cancers are aneuploid. However, the precise role that chromosomal instability plays in the development of cancer and
in the response of tumours to treatment is still hotly debated. Here, to explore this question from a theoretical standpoint
we have developed an agent-based model of tissue homeostasis in which to test the likely effects of whole chromosome
mis-segregation during cancer development. In stochastic simulations, chromosome mis-segregation events at cell division
lead to the generation of a diverse population of aneuploid clones that over time exhibit hyperplastic growth. Significantly,
the course of cancer evolution depends on genetic linkage, as the structure of chromosomes lost or gained through mis-
segregation events and the level of genetic instability function in tandem to determine the trajectory of cancer evolution.
As a result, simulated cancers differ in their level of genetic stability and in their growth rates. We used this system to
investigate the consequences of these differences in tumour heterogeneity for anti-cancer therapies based on surgery and
anti-mitotic drugs that selectively target proliferating cells. As expected, simulated treatments induce a transient delay in
tumour growth, and reveal a significant difference in the efficacy of different therapy regimes in treating genetically stable
and unstable tumours. These data support clinical observations in which a poor prognosis is correlated with a high level of
chromosome mis-segregation. However, stochastic simulations run in parallel also exhibit a wide range of behaviours, and
the response of individual simulations (equivalent to single tumours) to anti-cancer therapy prove extremely variable. The
model therefore highlights the difficulties of predicting the outcome of a given anti-cancer treatment, even in cases in
which it is possible to determine the genotype of the entire set of cells within the developing tumour.
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Introduction
Cells with a wide range of structural and numerical defects in
chromosomes are found in many types of cancers. Whether these
changes contribute directly to the evolution of cancer or are just a
by-product of carcinogenesis itself, however, is a question that has
puzzled cancer researchers for more than a century. Although
there is strong experimental evidence for changes in chromosomal
copy number (aneuploidy) and chromosome mis-segregation
playing a central role in the way cancer evolves [2], no organizing
principles or clear evolutionary pathways have been established.
Therefore, an alternative approach is to study the problem from a
theoretical viewpoint, using simple computational models of cell
behaviour and cell-cell interactions to study homeostasis, its
dysregulation during cancer progression and its response to
treatment [3].
Computational modelling has recently become a practical
approach for the study of such emergent behaviours and complex
phenomenon [4]. Agent-based models have been used with success
to model the complexity found in ecological [5], economical [6]
and cancer systems [7], [8]. In complex systems, global behaviour
emerges from the interactions of the individual components, and
cannot always be inferred from an analysis of the individual
components in isolation [9]. Instead, however, agent-based models
can be used to determine the effects of interactions between
individual components on the behaviour of the system as a whole
[10]. One of the main advantages offered by agent-based
modelling over equation-based modelling techniques is the ability
to study the emergent behaviour that arises from defined
interactions between elements of a complex system [11]. Because
cancers are made up a large number of cells of diverse genotypes
that interact without centralised control, agent-based modelling
may help capture the essence of the system from the behaviour of
individual cells. Inspired by this type of computationally tractable
model, we have developed a framework with which to analyse the
role of chromosomal instability in cancer progression, and to
investigate the impact of chromosome mis-segregation in cancer
treatments. In silico experiments were then carried out to simulate
the interaction between chromosome mis-segregation and cancer
treatments; including abstractions of surgery, the physical removal
of tumour mass, chemotherapy, a treatment where over-prolifer-
ating cells are targeted and killed; and a combination of these two
treatments. It is clear from simulations that cancers with an
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unstable complement of chromosomes have a worse overall
prognosis. Moreover, the two types of therapy work in distinct
ways enabling them to be combined to further delay the course of
cancer progression. Finally, the analysis makes clear the difficulties
of predicting the course of any one cancer or its response to
therapeutic intervention.
Results and Discussion
The Model
To address whether chromosome missegregation plays an
important role in the development and progression of a cancer
we developed a simple model of tissue homeostasis in which to
study cancer evolution. To focus our analysis on this poorly
understood phenomenon we chose to disregard other types of
mutations (such as substitutions, insertions, deletions, and chro-
mosome translocations). For this, individual cells were modelled,
each equipped with a genetically defined genome, as agents in a
computational simulation (see Methods). We then represent the
tissue as a linear array of individual cells, where daughter cells are
spatially introduced adjacent to the mother cell of origin. The
simulated tissue initially exhibits homeostatic behaviour, as the
result of balanced rates of cell proliferation and cell death. These
behaviours were modelled as stochastic processes that are
regulated at a genetic level, based upon the properties of known
proto-oncogenes and tumour suppressor genes [12]. While in real
biological systems many features of cell biology are polygenic, we
made the simplifying assumption that a single gene dominates in
the regulation a specific behaviour, and that the impact of each
gene is proportional to the number of copies of a given gene found
in the genome of each cell, as suggested by recent studies on the
effects of differences in chromosome number on gene expression in
biological systems [13], [14]. This simplification is a necessity
while the human genetic regulatory network remains unknown. In
addition, it is key to understanding the effect of missegregation
events that affect chromosomes containing key genes such as p53,
Ras and pRb [12]. Thus, while reality is much more complicated,
we anticipate that it will be possible in the future to apply the
insights obtained by addressing this fundamental problem in an
abstract way to human cancer. Having established this model
system, we then introduced a gene abstraction that regulates
fidelity during cell division, which enable us to test the role of
evolving chromosomal instability in cancer development and
treatment. In this way, we can isolate the effects of chromosome
instability, tumour suppressor and oncogene activity and genetic
linkage on cancer progression (see Figure 1 A).
Each cell in the system has a simulated genome composed of
three kinds of genes. Apoptosis regulatory genes are an
abstraction of tumour suppressor genes such as p53 [15] that
regulate cell death, and enable us to model the fact that tissue
crowding leads to a corresponding increase in the rate of
delamination and cell death within an epithelium to maintain
homeostasis [16] [17]. To balance cellular death, cell division
regulatory genes provide an abstraction of proto-oncogenes
such as Ras [18], Myc [19] and p110 PI3K [20] and act to
promote cell growth and cell cycle progression. Again the action of
these genes is sensitive to the ‘‘homeostatic capacity’’ of the tissue
in order to model the process know as contact inhibition that limits
cell proliferation in crowded tissues [17]. Thus, in combination
these controls ensure that if the number of cells exceeds the
homeostatic limit, proliferation is inhibited and the probability of
cell death increased, maintaining a constant population of cells
close to the homeostatic capacity of the simulated tissue.
In addition, the model contains a finite rate of chromosome mis-
segregation during cell division, which generates variation
amongst the cell population. This level of genetic variation
depends on the action of chromosome segregation regula-
tory genes, which model genes controlling the fidelity of cell
division such as BUB1 [21] and MAD2 [22] that reduce the
likelihood of chromosome mis-segregation at cell division. In the
initial population of cells, each cell has two sets of identical
chromosomes (a diploid genome) and 2 copies of the chromosome
segregation gene. When dividing, the genome of each cell is
duplicated and the two sets of chromosomes are then segregated
into two daughter cells. It is during this stage that chromosome
mis-segregation events can occur, resulting in asymmetric cell
division: one daughter cell with an extra chromosome, and one
lacking the same chromosome.
Simulating Chromosome Missegregation
Because the exact role, location and linkage of the key genes
regulating cell growth, death and chromosome segregation in real
human chromosomes remains unknown [23], here we have also
explored how differences in the distribution of genes on
chromosomes affects the evolution of the system as a whole. To
do this, we placed the abstracted genes in three different
chromosomal configurations (Figure 1 A). These are distribution
A, where apoptosis regulatory genes and cell-division regulatory
genes are ‘‘linked’’ in the same chromosome; distribution B, where
cell-division regulatory genes and chromosome segregation
regulatory genes lie on the same chromosome; and Distribution
C where genes regulating apoptosis and chromosome segregation
are genetically linked. At the start of simulations each cell was then
modelled as a diploid, containing two copies of each chromosome
(Figure 1 A).
The evolutionary dynamics in our model are then determined
by the gene expression of the individual cells and the global
Figure 1. Genotype configurations and Gene Key. A. The
different Gene Abstractions were placed into chromosomes in three
different configurations. This led to different kinds of linkages between
the Genes. B. For the notation of different genotypes, we have used the
following key: (Number of Division Genes, Number of Death Genes,
Number of Segregation Genes). The initial Genotype in every simulation
is a diploid genome: (2,2,2). To better understand the proportions of the
genes in a given phenotype, we have used the RGB model to represent
the number of division genes as red, the number of death genes as
green and the number of segregation genes as blue See Methods,
Genotype Key).
doi:10.1371/journal.pone.0072206.g001
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behaviour that emerges through cell death, proliferation and mis-
segregation over time. Focusing on the genotypes that emerge
throughout the simulation, we denote the initial state as (2, 2, 2):
corresponding to 2 functional copies of each gene (Division,
Apoptosis and Segregation, respectively as seen in Figure 1 B).
Cancer-like growth will ensue if the number of oncogenes
increases and/or if all tumour suppressors are lost. Exploring the
three different gene distributions, 100 simulations were performed
for each configuration (Figure 2 A). Because instances of cell
division, birth and cell death are expected to be stochastic in
nature, and have been modelled as such, the behaviour of the
system is highly variable. Nevertheless, consistent trends can be
observed as illustrated in Figure 2 B.
First, Gene Distribution A resulted in homeostatic behaviour, in
which the system as a whole responds to fluctuations in cell
number to maintain the total number of cells close to that of the
carrying capacity of the tissue (200 cells). As expected, the plot of
the total number of cells across the simulations of Distribution A
revealed increasing variability in the genetic make-up of individual
cells over time as the result of chromosome mis-segregation
induced genetic drift; similar to that which might be seen in an
ageing homeostatic tissue. Although this variation makes the
statistical analysis challenging, an invariant behaviour can be
observed for each configuration; best visualized by broom plots in
Figure 2 B. In this case, because the abstracted genes that model
the role of oncogenes and tumour suppressor genes were coupled
by being situated on the same chromosome, the balance between
death and division was maintained despite the generation of new
genotypes emerged through chromosome mis-segregation events.
Significantly, some of the more successful genotypes naturally
acquired more resistance against chromosome mis-segregation,
through the acquisition of an extra copy of the chromosome
segregation regulatory gene (genotype state (2,2,3)), as seen in
Figure 2 E. This kind of stable aneuploid karyotype is found in
normal homeostatic tissues [24].
For Gene Distribution B, the gradual accumulation of
chromosome mis-segregation events leads to a breakdown in
homeostatic behaviour, giving rise to uncontrolled proliferation
(Figure 2 B). Once this occurred, total cell number increased
exponentially, reaching the values of the order of thousands in a
very short period of time. This kind of over-proliferative behaviour
was consistent across simulations. An analysis of the emergent
genotypes evolved through Gene Distribution B, as seen in Figure 3
B, revealed that aneuploid genotypes such as (3,2,3) and (2,1,2)
take over the population. From these aneuploid genotypes, initially
only slightly different to the original one, the population branches
out to generate more malignant genetically distinct variants such
as (3,1,3) and (2,0,2). Different kinds of successful (and less
successful) genotypes are gradually evolved. Successful genotypes
have the qualities of being apoptosis-resistant (low number of
apoptosis genes, as seen on Figure 2 D) and over-proliferative
(increased number of division genes, as seen on Figure 2 C). In this
distribution, however, because the genes that regulate division are
coupled to those that regulate fidelity during segregation (Figure 2
E), there is a brake applied to the subsequent generation of
aneuploid genotypes with increased division rates. As a result, this
population of aneuploid cells remained relatively homogeneous
once cells had acquired the key genetic anomalies driving
deregulated tumour growth (Figure 2 F). This kind of evolution
observed across experiments suggests a possible pathway for
oncogenesis that is associated with stable aneuploidy [24]. Diseases
such as leukaemia, lymphomas and some mesenchymal tumours
that exhibit specific abnormalities may follow a similar path [25].
Simulations of Gene Distribution C displayed over-proliferative
behaviour, similar to that of Gene Distribution B (Figure 2 B). On
a closer inspection, however, significant differences in the
dynamics of cancer evolution were observed (Figure 3 B). Because
the genes that regulate death are genetically linked to those that
regulate segregation in Gene Distribution C (Figure 2 D and
Figure 2 E), cancer evolution was accompanied by an increase in
genotypic diversity as the drive to lose apoptosis regulators leads to
a concomitant deregulation of chromosome segregation (Figure 2
F), as in genotype (3,1,1) and then genotype (3,0,0). This in turn
drives to the emergence of ever more aggressive clones (4,0,0),
(5,0,0) and (6,0,0), which corresponds to a 3-fold increase in the
rate of cell proliferation (Figure 3 B). This serves as a model for the
emergence of heterogeneous tumours, like those seen in clinical
settings, for example during the neoplastic progression character-
istic of epithelial tumours [26] [27]. These simulations for
Distribution B and C show how chromosome mis-segregation
events can drive tumour evolution by breaking the regulatory
balance that maintains normal tissue homeostasis.
To test the effects of leaving genes unlinked, a fourth genetic
distribution was investigated by modifying the model to accom-
modate a third chromosome. This system exhibited all three
behaviours obtained previously in stochastic simulations: pro-
longed homeostasis (as in Distribution A), unregulated growth
driven by loss of tumour suppressors (Distribution B) or by
oncogene activation (Distribution C), We also observed three kinds
of chromosome segregation event: up-regulated (Distribution B),
down-regulated (Distribution C) and neutral. This control
experiment shows how linkage between genes serves to limit the
common evolutionary paths exhibited by the system.
Chromosome Missegregation in Cancer Therapies
In patients, tumours composed of cells that are chromosomally
unstable have been associated with a poor prognosis [28]. We
therefore used Gene Distributions B and C (Figure 3 A) to
determine the relative efficacy of different treatment strategies in
dealing with tumour evolution under conditions of low and high
levels of genome instability. We considered tumour detection
would occur when the population reached 1000 cells. By the same
token, we considered that the tumour had relapsed when it again
reached the 1000 cell mark after treatment (marked as vertical
lines in Figure 3). Using these measures, we modelled the outcome
of different treatments on single tumours (or patients), so that we
could directly compare the outcomes in each case, despite the
expected variability in the course of tumour growth between
different simulations (tumours/patients). Data for a representative
experiment for each simulation are shown in Figure 3.
Scenario i: Surgical Treatment. The simulation of tumour
removal was implemented by retaining the first 100 connected
cells in the linked list and removing the rest of the connected
component of 900 cells in a single time-step. Since the tumour
rapidly emerged from a homeostatic population of 200 cells, the
vast majority of these represent cells related to cells in the tumour.
Scenario ii: Chemotherapy: To simulate the effects of chemother-
apy, we implemented an algorithm that killed all the cells that
attempted cell division in the nine consecutive time steps following
tumour detection. Scenario iii: Combination Therapy. As in
common in the clinic we combined therapies by implementing
surgery followed by nine rounds of chemotherapy.
Surgery was modelled to mirror the clinical intervention. Thus,
it was implemented when the population of cells has broken
through the homeostatic limit of 200 cells, and grown to reach
1000 cells. At this point, the population is made up of descendants
of many of the cells present in the initial population used to seed
Chromosome Missegregation in Cancer Development
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the simulation, but is dominated by a small number of related but
genetically heterogeneous aggressive cell clones, as in human
cancers [29]. The population also includes cells poised in a pre-
cancerous state that are the product of a process analogous to field
cancerization [30] which occurs as cells compete for space during
the course of simulations. These pre-cancerous cells will be likely
be related by lineage to the aggressive sub-clones that constitute
the bulk of the tumour. At this point, 90% of the population were
removed (Scenario i). To implement this, ‘‘adjacent’’ cells were
removed from the cell list to mimic surgical removal of the tumour
bulk. It is important to note that these cells tend to be related by
lineage as the result of cell division, as do the 10% of cells that
remain.
When we then examined the recovery following therapy, results
proved highly variable and depended on the nature of the cells
that survived (Figure 3 C and Figure 4 A). Though the actual
evolutionary pathways exhibit a high degree of variation across
simulations, a representative experiment for each gene distribution
captured qualitatively the kind of evolutionary pathway that most
of the simulations followed, as shown in Figure 3 C. After surgery
an average of 105 cells were left (std. 4.50) for distribution B and
106 cells (std. 5.13) for distribution C. However, over 100
simulations the prognosis was significantly better (p = 0.0499) for
tumours with Gene Distribution B, which exhibit relatively low
levels of chromosome mis-segregation (relapse time was an average
of 35.22 time steps and a standard deviation of 8.33), compared to
those with Gene Distribution C and high levels of chromosome
mis-segregation (with an average of 32.84 and a standard deviation
of 8.70), as seen in Figure 4 A. This behaviour was due in part to
the greater likelihood of a relatively normal population of cells
remaining after surgery from a population with low genetic
heterogeneity in comparison to that from a highly heterogeneous
population. Simulation to simulation variability in the path to
relapse was determined in part by the kind of genetic aberrations
present in the population remaining following surgery. Thus,
remaining cells that had suffered a loss of tumour suppressors
would not over-proliferate until they underwent additional mis-
segregation events, delaying the period of time until relapse. In
contrast, for simulations in which over-proliferative genotypes are
the first to emerge, a subset of cells remaining after surgery quickly
re-grow to break through the homeostatic limit (inhibiting the
growth of normal neighbouring cells through competition for
space) to form a tumour. Thus, the relapse time in simulations is
determined, primarily, by the oncogenic load, which is higher in
the chromosomally unstable populations.
Next we explored the role of genetic linkage in the course of
tumour relapse following surgery. For this analysis, as a measure of
the types of lesion driving tumour formation and relapse, we
compared the ratio of the average number of Apoptosis Genes to
the average number of Division Genes in simulations (shown in
Figure 5 A). When this was analysed in the 25 time steps after
surgery, it was clear that Gene Distribution C has a reproducibly
higher rate of loss of Tumour Suppression and Oncogene
acquisition than Distribution B. This can be seen most clearly
by comparing changes in the rate of the ratio of the average
number of Apoptosis Genes to the average number of Division
Genes following treatment (Figure 5 A), which has an near linear
slope of 20.0067 (std. 0.0037) for Distribution C, which is
significantly steeper (p = 0.005E-1) than the average slope for
Distribution B (slope 20.0049, std. 0.0030). This reflects the
greater generation of more malignant novel genotypes in type C
simulations, where chromosomal instability is high, compared to
simulations for Distribution B, where aneuploidy is relatively
stable. This in turn correlates with a worse prognosis for the
genetically unstable tumours. Thus, in our simulations, surgery
acts as a hit-or-miss therapy because it leaves cells that are related
to each other.
Having carried out an analysis of the effects of surgery, we next
simulated chemotherapy in the model (Scenario ii). Chemotherapy
was implemented in consecutive rounds, as done in the clinic using
a treatment such as taxanes, to specifically target dividing cells
[31]. This therapy tends to remove cells of the tumour that have
deregulated division, but also targets cells in the pre-cancerous
population that have deregulated proliferation and normal cells
that happen to divide. After chemotherapy, an average of 226.17
cells (std. 53.12) were left for Distribution B and 231.88 (std. 50.06)
cells for Distribution C. These cell numbers reflect the mechanism
by which chemotherapy acts: killing an average of 15.76% of the
population of Configuration B (std. 0.47), and 16.3% of the
population of Configuration C (std. 0.70) at each time step. In this
way the course of treatment drives an exponential decrease in the
number of cells killed.
When examining the effect of genetic linkage on the recovery
following chemotherapy we found that the relapse time was again
faster for cell populations with Gene Distribution C. Thus, Gene
Distribution B relapsed on average at 21.95 time steps (std. 4.89),
while tumours recurred in Gene Distribution C at an average of
18.30 time steps (std. 3.42), as seen in Figure 4 B. Again, this
significant difference (p= 0.003E-5) in relapse time could be
attributed to differences in genetic diversity between the two
populations at the time of treatment. Moreover, when we
measured the rate of acquisition of new variants that have
increased oncogenic load and a reduced number of tumour
suppressor genes (the ratio of the average number of Apoptosis
Genes to the average number of Division Genes) there was a
marked and significant difference (p = 0.004E-7) between simula-
tions over 25 time steps after chemotherapy - an average slope of
20.0048 (std. 0.0016) for Distribution B, and 20.0068, (std.
0.0019) for Distribution C (as seen in Figure 5 B). This reflects the
presence of higher numbers of cells poised in a pre-cancerous state
following treatment in Distribution C.
Finally, a combination of the two therapies (Scenario iii) yielded
an overall better prognosis for the two gene distributions than
surgery or chemotherapy alone. After this combined therapy there
were on average 36.09 (std. 8.56) cells left for Distribution B and
36.29 (std. 7.99) cells for Distribution C. Again, the results indicate
that Gene Distribution B still has a significantly better prognosis
(p = 0.008) than Gene Distribution C: Gene Distribution B had an
average relapse of 46.55 (std. 10.06), while Gene Distribution C
had an average relapse of 43.09 (std. 9.44). These results can be
Figure 2. Analysis of simulations. A. The three genetic arrangements, in simulated diploid chromosomes. Key measurements of each
configuration are represented in Broom Diagrams. B. Aspects of each simulation, from total number of cells to genetic diversity are represented as
line of different colour, with the median as a thick, black line (calculated until one of the simulations came to an end). The behaviour observed for
Gene Configuration A is a homeostatic one. Configurations B and C displayed an over-proliferative behaviour. This is due to the genetic up and down
regulation reflected by the change in the average number of key genes across time. C. The average number of Division Genes. D. The average
number of Apoptosis Genes. E. The average number of Segregation Genes. F. The genetic diversity, liked to the number of Segregation genes, had a
profound effect on the Genotypic Diversity, being greatest in Configuration C. Colours are purely used to distinguish runs and do not denote genetic
distribution.
doi:10.1371/journal.pone.0072206.g002
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compared across scenarios in the form of histograms in Figure 4 C.
Again, the overall impact of genetic linkage on the evolution of the
tumour after treatment can be most easily visualized by comparing
the average slope of the ratio between Apoptosis and Division
Genes (Figure 5 C). When we considered the 25 time steps after
therapy, this shifted significantly (p = 0.005E-2): 20.0036 (std.
0.0025) for Distribution B and 20.0052 (std. 0.0034) for
Distribution C.
Figure 3. Genotype diversity. A. The two over-proliferative genetic arrangements, in simulated diploid chromosomes, and the RGB key in the
middle. We have used the RGB colour model to visually describe the different genotypes that evolve in the system by normalizing the maximum
observed Genotype State (See Methods, RGB Key). We have assigned a colour to each of the abstracted genes: Red for division, green for death and
blue for segregation. By comparing via an RGB system the colours assigned to a given genotype, we are able to tell visually the proportions in which
the genes are distributed, with intensity values corresponding to the number of genes: (0,0,0) being black, the initial genotype (2, 2, 2) being dark
grey and the maximum observed genotype (5, 5, 5) being white. B. Representative Marble Diagram for a simulation with the Model. These diagrams
display the stacked percentage of Genetic Diversity across time for a representative simulation of Gene Configurations B and C across different
scenarios. The beginning of therapies (when reaching 1000 cells) are marked with a black vertical line, while relapse times (when reaching again 1000
cells) are marked using a dashed line. C. Representative Marble Diagram for a Simulation of Surgery. D. Representative Marble Diagram for a
Simulation of Chemotherapy. E. Representative Marble Diagram of a therapy combination of Surgery followed by Chemotherapy.
doi:10.1371/journal.pone.0072206.g003
Chromosome Missegregation in Cancer Development
PLOS ONE | www.plosone.org 6 August 2013 | Volume 8 | Issue 8 | e72206
Conclusions
Tumours have been recognised as aneuploid for over a century
[32]. In addition, recent genomic sequencing studies have revealed
enormous heterogeneity within single tumours, the role and
consequences [33]. Nevertheless, the role of chromosome mis-
segregation in cancer development is still debated, and experi-
ments testing the effects of perturbing rates of chromosome
segregation on tumour formation in mice have yielded contradic-
tory results [34]. Therefore, to better understand the roles of
chromosomal instability in the evolution of tumours, we decided to
take a theoretical approach and developed an agent-based model
of whole chromosome mis-segregation during cell division, in
which to determine how chromosome mis-segregation might
contribute to cancer initiation.
For this purpose, we focused on modelling individual cells and
their genomes in a homeostatic tissue whose behaviour is
determined by a balance of cell death and cell proliferation within
the context of a constrained environment. When events of
chromosome mis-segregation are introduced, however, the
dynamics of the system change in such a way that new, interesting
complex behaviours emerge, which can be used to shed some light
on the basic principles of aneuploidy in tumourigenesis. In
simulations, chromosome mis-segregation events generate novel
genotypes that promote unregulated cellular proliferation and
impair cellular death, driving cancer development. Importantly,
this analysis also revealed that the location of these genes across
chromosomes plays a key role in determining the system’s
behaviour and in shaping the genetic structure of the tumour
population [35]. This is driven by the fact that the copy number of
genes that regulate the fidelity of chromosome segregation can
alter as the result of the mis-segregation of their host chromosome
at cell division. As a consequence, differences in the rates of mis-
segregation evolve during the course of tumour development in a
way that depends on genetic linkage. So, for example, in the
absence of direct selection for chromosomes based upon the
presence of genes promoting or inhibiting cell proliferation (Gene
Distribution A), we observed a reproducible increase in the
number of clones with a decreased rate of chromosome mis-
segregation.
In our model we observe two distinct pathways for evolution
towards oncogenesis that have a direct impact on the tumour’s
response to treatments. In the first case, dominant proliferating
clones within the tumour exhibit a relatively stable state of
aneuploidy driven by the acquisition of genes that ensure the
fidelity of chromosome segregation along with division genes that
encourage proliferation. In the second, selection for the loss of the
chromosome segregation regulatory genes together with the loss of
tumour suppressors results in tumours that continually generate
increasing levels of heterogeneity and ever-more malignant
subclones. This latter pathway exhibited a more rapid expansion,
suggesting that chromosomally unstable tumours are inherently
more aggressive.
In this analysis we also explored the effects of 3 different types of
simulated treatment in each case: surgery, chemotherapy and
combination therapy. When comparing surgery and chemother-
apy, it is important to note that the way in which the two therapies
are implemented has important implications for interpreting the
relapse data. First, when studying the effects of surgery, it was
necessary to compare the genetic make up of cells in the simulation
immediately before and after surgery. To do so, we compared the
genetic make up of the 1000 cells in the time-step prior to the
intervention, with the average of 100 cells in the time step
following the intervention. The abrupt change in cell numbers
generates a shift in make-up of the population, which leads to a
marked increase in apparent population heterogeneity immedi-
ately following treatment. By contrast, when the chemotherapy
treatment is implemented in a population reaching 1000 cells, the
intervention leads to a variable decrease in population size with
each time step that depends on the proliferation rate. On average
this yielded a 16% decrease in the population size (840, 706, 593,
498, 418, 351, 295, 247 and 208 in the last time step of the
intervention). This caused a smoother transition that depends on
the precise impact of the treatment on the population.
These differences are reflected in the larger variation across
simulations in the response to surgery compared to chemotherapy
(Figure 5), which translates into chemotherapy being a consistent
therapy, while surgery is a ‘‘hit or miss’’ therapy that can on
occasion cure the tumour. Thus, although surgery appeared to
have a better overall prognosis than chemotherapy in the
simulations, there is a lag time required before the population
Figure 4. Distribution of the response to treatments under
different scenarios. The histograms correspond to a measure of the
distribution of the relapse times (the time it took each simulation to
grow back to 1000 cells after treatment) for 100 simulations of each
gene configuration under three different therapy scenarios: A. Surgery
Scenario, B. Chemotherapy Scenario and C. Combination of both
treatments (Surgery followed by Chemotherapy).
doi:10.1371/journal.pone.0072206.g004
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following surgery recovers reaches levels seen following chemo-
therapy. Thus, it took 9 time steps for Configuration B to recover
to yield an average of 210 cells (std. 33.08) and 8 time steps for
Configuration C to reach on average of 205 cells (std. 42.64).
When this difference is taking into account, both therapies are seen
to yield a similar overall prognosis, which enables the differences
in the patterns of recovery in the two cases to be usefully compared
using this implementation (Figure 5 A and Figure 5 B).
Nevertheless, clear differences in the trajectory of relapse were
seen following surgery and chemotherapy. A comparison between
the ratio of the average number of Apoptosis Genes to the average
number of Division Genes following surgery (Figure 5 A) and
following chemotherapy (Figure 5 B) helps to reveal the key
differences. In the first case, the mean number of apoptosis
regulatory genes is, averaged over many simulations, increased
towards diploidy following surgery. At the same time as the
average number of division regulatory genes is decreased towards
Figure 5. The average ratio of apoptosis to division genes. These graphs show the tendency of reducing the number of apoptosis genes and
increasing the number of division genes with respect to time across different scenarios: A. Surgery Scenario, B. Chemotherapy Scenario and C.
Combination of both treatments (Surgery followed by Chemotherapy). The dark line is the median of the samples and the shadowed area represents
the variance. Interventions were carried out at time step zero. The reported slopes were measured taking into account 25 time steps after each
therapy.
doi:10.1371/journal.pone.0072206.g005
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diploidy across simulations. This sharp increase in the average
number of apoptosis genes and decrease in the average number of
division genes gives rise to a sudden change in the slope of their
ratio as depicted in Figure 5 A. It is important to note that while in
some cases the recovery to diploidy was almost total, in many
others the recovery was less pronounced or even counter-
productive. Although on average a dramatic shift towards diploidy
of a given chromosome can be observed, the spread of the results
point to a large number of cases where surgery leads to the total
loss of tumour suppression (with intact diploid division genes), an
accelerated gain in oncogenes (with normal levels of tumour
suppression) or a lethal combination of both. This leads to
variability in the outcomes of surgery that depend on the limits of
the cell population removed [29], and the extent of field
cancerization in the tissue [30]. These subtle but complex
dynamics in surgery are best observed on a case-by-case
examination of the evolved genotypes, as those shown in Figure 3
B and Figure 3 C.
Under the chemotherapy scenario, the treatment also leads to
an average reduction in the oncogenic load, as the result of the
selective killing of dividing cells. This therapy, does not however
offer relief from the steady loss of genes regulating apoptosis. As a
result, the ratio of apoptosis genes and division genes remained, on
average, nearly constant under these conditions, as can be seen by
a slight change in the slope of their ratios after chemotherapy
(Figure 5 B). It seems intuitively likely that chemotherapy, by
selectively targeting actively proliferating cells, would prove a
more effective treatment than surgery. However, our model shows
that the result of treatment is complicated by the fact that there are
two kinds of cells that underlie relapse. There are cells that have
lost tumour suppression and cells that have acquired oncogenes.
While surgery acts against both types of cell, chemotherapy cannot
target cells that are no longer subject to apoptosis-mediated
tumour suppression but which divide slowly. As a result of this
bias, the recovery following treatment is characterised by different
trajectories in the ratio of Apoptosis to Division Genes in the two
cases. This unexpected result highlights the importance of these
kinds of abstract models as aids to understanding the likely path of
tumour evolution.
It is also possible to use these simulations to examine the
chances of remission. Following both surgery and chemotherapy,
the most successful individual cases were accompanied by the
recovery of genotypes with active tumour suppression. If tumour
suppression is not recovered, the treatment fails. Thus, if a large
proportion of cells retain functional tumour suppressors at the time
of therapeutic intervention, it is possible to recover less aggressive
genotypes through treatment, leading to a better prognosis.
Conversely, if tumour suppressor function is compromised prior
to treatment in the bulk of the population, e.g. through field
cancerization, the intervention can lead to an evolutionary
bottleneck that selects for the rapid expansion of the most
malignant cells in the population. Thus, while the speed of relapse
in aggressive cases is dominated by the action of oncogenes that
drive proliferation, a sustained recovery following treatment
depends largely on tumour suppression.
These results suggest that targeting chromosomally unstable
cells may be an important part of future cancer therapies. It has
been suggested that chromosomal instability may also play a role
later in generating the genetic diversity required for cancer cells to
survive the trials of invasion and metastasis, something that we
have not explored here. Only through the tracing of clear
evolutionary pathways in real cancers will it be possible to
understand the different roles that these complex mutations have
throughout the process of carcinogenesis and thus help us to
develop better treatments. Future work will be needed to assess
how scrambling of the genome may combine with mis-segregation
events to drive the evolution of chromosomes that have specific
complements of genes.
In sum, in exploring the evolutionary pathway of cancer clones
in tumour development our model shows the interplay between
aneuploidy and tumour therapies. Future research will need to
build on such models to being them closer to reality; to study the
role of aneuploidy on more advanced kinds of tumours, and to
simulate other kinds of cancer treatments.
Methods
Agent-based Model Algorithm
All cells are ordered in a linked list, and each cell has a
simulated genome composed of three kinds of genes. Each of the
three genes code for corresponding actions at a cellular level,
inspired by biological systems and known cancer genes [12]. The
genes present and their functions, described below, are:
N Tumour Suppressors- Apoptosis Regulatory Genes
N Proto-oncogenes- Cell Division Regulatory Genes
N Genetic stability- Chromosome Segregation Regulatory Genes
The homeostatic constraints in the model were abstracted from
real biological systems, where the overall goal of homeostasis is to
maintain the tissue’s relative constant size and shape [36]. The
homeostatic size of the tissue is established for each experiment
through an allocated space parameter, where measurements for
homeostasis are based on global cell count. Although this model is
not spatially explicit, there is a degree of spatial structure in the
model since new daughter cells are introduced in the linked list of
cells spatially replacing the cell of origin after division.
Inspired by the processes in biological cellular behaviour
through which homeostasis is maintained in organisms, the
algorithm is as follows:
1. An initial population of 100 cells is created, each with diploid
chromosomes. Each initial genome was equipped with 2 copies
of each type of gene, grouped into chromosomes according to
the gene distribution type A, B or C. The normal carrying
capacity of the tissue is fixed at 200 cells.
2. For each time step, the total number of cells is measured and is
not updated until the next time step.
3. If a measurement of the total number of cells is greater than the
tissue’s carrying capacity, then the probability of cell death is
calculated. The probability of death depends on the number of
available copies of the apoptosis regulatory genes, Nap, within
each cell’s genome. The probability of apoptosis, pap, is
determined by:
pap~rapNap
Where rap is a parameter for the rate of apoptosis. The cell is then
killed with a probability of pap.
4. If the cell has not died, it has a chance to divide. The
probability of division depends on the number of available
copies of the division regulatory genes, Ndiv, and a parameter
that determines the rate of division, rdiv. The probability that a
cell divides, pdiv, is:
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pdiv~rdivNdiv
5. If dividing, a new cell is introduced in the linked list, spatially
adjacent to the mother cell (Figure S1 A), and the probability of
chromosome missegregation is calculated. If there is a
chromosome missegregation event, one chromosome chosen
at random is asymmetrically distributed during cell division
leading to the creation of two aneuploid cells. Otherwise, the
genome is duplicated and copied with fidelity, thus generating
two identical daughter cells. The probability of chromosome
missegregation, pmsg, in the model is:
pmsg~rmsg(4{Nmsg)
Where Nmsg is the number copies of the chromosome segregation
regulatory genes within the cell’s genome, and rmsg is a parameter
for the rate of chromosome missegregation.
The update rules are applied synchronously to all the cells in
each time step. Also, it is important to note that the probabilities
are conditional (i.e one probability depends on the previous one, as
described in the algorithm). For instance, the probability of
chromosome missegregation seems to be the largest, but because it
can only happen conditional to the probability of division, it is in
reality low.
Experiments
To investigate the properties and the dynamics of the system,
and specifically the role that chromosome segregation regulatory
genes have, four genome distributions were considered: Three
reported here and a fourth distribution that considers every gene
to be uncoupled as a control experiment. The parameter settings
were determined through a series of preliminary experiments, in
order to ensure that the behaviour of the system was both
biologically plausible and computationally feasible. Simulations
were carried out with the following initial parameters:
N Initial population: 100 cells
N Homeostatic size of the tissue: 200 cells
N Simulation end time: when reaching 7000 cells or reaching
300 time steps
N rap =0.045, rdiv =0.045, rmsg =0.02
Treatments
Scenario i: Surgery: Once the size of the population had
reached 1000 cells, a segment of the linked list that contains 900
cells is selected and deleted, leaving a residual segment of 100
(Figure S1 B). Scenario ii: Chemotherapy: An algorithm kills all
the cells that attempt cell division in the nine consecutive time
steps after the list has reached 1000 cells (Figure S1 C). Scenario
iii: Combination Therapy. Surgery is implemented, followed by
nine rounds of chemotherapy.
There is an important difference between the two treatments.
When carrying out a surgical procedure, the cancer is removed
along with some surrounding tissue at the tumour margin whose
extent depends on the location and the extent of tumour invasion
[29]. To capture these aspects of the treatment, surgery in the
model was implemented as the removal of 90% of the cells in the
‘‘cell list’’. The proliferation algorithm is implemented so that cell
division generates related neighbouring cells.
Genotype Key
For the analysis of the simulations, the emergent genotypes were
assessed. By quantifying the number of chromosomes that a cell
has at a given time, a genotype state GT is defined as:
GT~(Ndiv,Nap,Nmsg)
Where Ndiv, Nap and Nmsg are the number of copies of Cell
Division Regulatory Genes, Apoptosis Regulatory Genes and Chromosome
Segregation Regulatory Genes respectively. The initial genotype consists
of two functional copies of each chromosome: genotype state (2, 2,
2).
RGB Key
Colours in the RGB model are defined by three components
(Figure 3 A). Because of this, a three-dimensional volume is
described by treating the component values as ordinary Cartesian
coordinates in a Euclidean space. For the RGB model, this is
represented by a cube using non-negative values within a 0–1
range, assigning black to the origin at the vertex (0, 0, 0), and with
increasing intensity values running along the three axes up to
white at the vertex (1, 1, 1), diagonally opposite black. An RGB
triplet (red, green, blue) represents the three-dimensional coordi-
nate of the point of the given colour within an RGB colour cube,
or its faces or along its edges in a simplified version. This approach
allows computations of the colour similarity of two given RGB
colours by simply calculating the distance between them: the shorter
the distance, the higher the similarity. We have taken advantage of
this to describe the different genotypes that evolve in our system by
normalizing the maximum observed Genotype State. We have
assigned a colour to each of the abstracted genes: Red for division,
green for death and blue for segregation. By comparing the
similarity of the colours assigned to a given genotype, we are able to
tell visually the proportions in which the genes are distributed, with
intensity values corresponding to the number of genes: (0,0,0) being
black, the initial genotype (2, 2, 2) being dark grey and the
maximum observed genotype (5, 5, 5) being white.
Statistical Test
For the statistical tests we used an unpaired t-test to determine if
the means of the results in our two sets of experiments
(Configuration B and C) are significantly different in key aspects
of simulated treatments.
Our null hypothesis is that the observed response of the two
configurations to treatments is due to chance. The alternative
hypothesis is that the observed response to treatments depends on
the configuration. For these tests, we have assumed a two-tailed
distribution and equal variance.
Supporting Information
Figure S1 Actions within the linked lists of cells. A.
When dividing, a new cell is introduced in the linked list of cells,
spatially adjacent to the mother cell. B. During surgery, a segment
of the linked list that contains 900 cells is selected and deleted,
leaving a residual segment of 100 cells. C. During chemotherapy,
all the cells that attempt cell division in the nine consecutive time
steps after the list has reached 1000 cells are deleted.
(TIFF)
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